<DOC>
	<DOCNO>NCT02251756</DOCNO>
	<brief_summary>Study objective To assess performance different application regimen Actinica® protection UV rays-induced erythema throughout 1 day sun exposure fair-skinned healthy subject ( phototype I III ) . Study center A total 20 subject enrol 1 site France . Methodology This monocentre , randomise , control , investigator-blind , intra-individual comparative clinical investigation . There total 6 visit subject . Each subject participate period maximum 35 day . Study population Healthy subject , male female , least 18-60 year old , phototype I , II III , pre-treated/pre-protected skin , meet specific inclusion/exclusion criterion . The clinical investigation conduct 2 part . Part 1 - SPF determination : To determine SPF Actinica® application two different amount ( 0.8 2 mg/cm2 ) . Part 2 - Sun exposure : To assess performance different application regimen Actinica® protection UVR-induced erythema throughout 1 day sun exposure .</brief_summary>
	<brief_title>Performance Different Application Regimens ACTINICA® Protection From UVR-induced Erythema After One Day Sun Exposure Fair-skinned Healthy Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<criteria>1 . Male female , 1860 year age , 2 . Subject Phototype I , II III , 3 . Subject individual typology angle ( ITA ) 2870° , 4 . Subject healthy skin / tan back , 1 . Subject obvious skin cancer form within test area , 2 . Subject hair treat area might interfere clinical investigation assessment , 3 . Subjects perform sun bath least four month enrolment , 10 . History sun allergy / Mallorca acne , active photo induce photo aggravated disease , abnormal response sun ( e.g. , photosensitive dermatosis , polymorphic light eruption , solar urticaria , systemic lupus erythematosus , dermatomyositis ) . 11 . The subject receive , apply take forbidden treatment within specified time frame prior Day 0 visit ( list available request )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>